Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Estradiol
Drug ID BADD_D00821
Description Estradiol is a naturally occurring hormone circulating endogenously in females. It is commercially available in several hormone therapy products for managing conditions associated with reduced estrogen, such as vulvovaginal atrophy and hot flashes. Some available forms of estradiol include oral tablets, injections, vaginal rings, transdermal patches, sprays, gels, and creams.[L11485,L11488,L11491, L11494,L11497,L11500,L11503] When used for oral or IM administration, estradiol is commonly synthesized as a pro-drug ester (such as [DB13952], [DB13953], [DB13954], [DB13955], and [DB13956]). Because it has a low oral bioavailability on its own, estradiol is commonly formulated with an ester side-chain. [DB00977] (EE) is a synthetic form of estradiol commonly used as the estrogenic component of most combination oral contraceptive pills (OCPs). Ethinyl estradiol is different from estradiol due to its higher biovailability and increased resistance to metabolism, rendering it more suitable for oral administration.
Indications and Usage Estradiol is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar and vaginal atrophy due to menopause, for the treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure, and for the prevention of post-menopausal osteoarthritis. It is also used for the treatment of breast cancer (for palliation only) in appropriately selected women and men with metastatic disease, and for the treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only).
Marketing Status Prescription; Discontinued
ATC Code G03CA03
DrugBank ID DB00783
KEGG ID D00105
MeSH ID D004958
PubChem ID 5757
TTD Drug ID D08QMX
NDC Product Code 76420-022; 0430-0721; 63629-4788; 43063-706; 0781-7119; 0169-5176; 70518-0920; 70934-541; 54348-702; 43063-717; 72189-183; 68788-7961; 38779-2261; 46144-400; 69238-1294; 0781-7104; 68025-066; 0378-4640; 70518-2595; 61919-195; 72189-198; 71335-0797; 50090-3645; 52483-9104; 0430-3754; 0023-5886; 0093-3223; 63083-1557; 42291-962; 60429-833; 0395-8065; 11014-0320; 11014-0321; 51862-334; 69238-1296; 0093-3541; 0574-2067; 65162-126; 68025-067; 65162-992; 0013-2150; 61919-278; 63629-8803; 42806-089; 0378-4641; 68788-7892; 70518-2829; 70934-215; 50261-110; 0378-3349; 68788-8063; 68968-6675; 69238-1295; 0378-4643; 49452-2801; 0078-0344; 0430-0722; 63539-021; 68788-7332; 68025-065; 12860-0218; 50090-5494; 0802-8065; 60429-834; 63629-8804; 0378-4620; 70934-506; 0781-7138; 68968-6637; 76420-680; 51862-332; 69238-1447; 68968-3437; 68071-2487; 71335-1973; 65162-993; 76420-023; 70518-2368; 0078-0343; 50419-453; 0378-4621; 0430-0720; 68025-083; 65162-995; 52483-9254; 0378-8770; 71335-1488; 52483-9504; 70518-2369; 0555-0887; 0078-0365; 68968-3410; 60870-0218; 24658-702; 0378-3361; 68462-711; 71335-0430; 24658-703; 0555-0899; 0378-3352; 51862-333; 69238-1629; 68968-3475; 0378-3360; 71335-0201; 48087-0159; 70934-927; 0781-7122; 66993-002; 71335-0226; 65162-989; 68968-6650; 54348-701; 17139-617; 68981-012; 65162-150; 65162-226; 60429-835; 47781-104; 0078-0345; 44132-009; 50419-455; 24658-704; 0378-4644; 0781-7133; 51552-0384; 50419-456; 69238-1631; 50090-1704; 50419-459; 76420-681; 53746-226; 50419-451; 0023-5887; 68025-086; 68071-2429; 0555-0886; 69238-1630; 63629-8802; 0781-7134; 65162-228; 76420-021; 68071-3394; 45541-1124; 70934-393; 50419-454; 0023-5888; 69238-1632; 68968-3450; 0378-4623; 50090-3327; 65162-997; 0781-7156; 68788-7102; 42291-426; 0378-3350; 42806-087; 0378-4642; 71335-0445; 69238-1293; 0115-1518; 0037-4801; 63629-8654; 0023-5885; 69238-1633; 0781-7136; 50261-104; 71335-1719; 70934-798; 63629-8713; 65162-148; 68968-6625; 0078-0346; 50419-452; 42806-088; 68968-6610; 38779-0869; 45802-097; 63187-741; 68981-013; 0781-7129; 0378-3351; 0378-4622; 76420-048; 50090-2321; 68968-3425; 65162-149; 70934-786; 0378-4619; 0781-7167; 70518-0834; 44132-001; 0781-7144
Synonyms Estradiol | Estradiol-17 beta | Estradiol 17 beta | Estradiol Anhydrous | Oestradiol | Estradiol-17beta | Estradiol 17beta | 17 beta-Estradiol | 17 beta Estradiol | 17 beta-Oestradiol | 17 beta Oestradiol | Progynova | Estradiol, (9 beta,17 alpha)-Isomer | Estradiol, (9 beta,17 beta)-Isomer | Estradiol, Monosodium Salt | Estradiol, Sodium Salt | Vivelle | Aerodiol | Estrace | Estraderm TTS | Estradiol Hemihydrate | Estradiol Hemihydrate, (17 alpha)-Isomer | Estradiol Monohydrate | Estradiol, (+-)-Isomer | Estradiol, (-)-Isomer | Estradiol, (16 alpha,17 alpha)-Isomer | Estradiol, (16 alpha,17 beta)-Isomer | Estradiol, (8 alpha,17 beta)-(+-)-Isomer | Estradiol, (8 alpha,17 beta)-Isomer | Estradiol Valerate | Estradiol Valeriante | Progynon-Depot | Progynon Depot | Delestrogen | Estradiol-17 alpha | Estradiol 17 alpha | Estradiol, (17-alpha)-Isomer | Ovocyclin
Chemical Information
Molecular Formula C18H24O2
CAS Registry Number 17916-67-5
SMILES CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Asthenia08.01.01.001--Not Available
Asthma10.01.03.010; 22.03.01.002--Not Available
Atrial fibrillation02.03.03.002--
Back pain15.03.04.0050.000626%
Basal cell carcinoma16.03.02.001; 23.08.02.001--Not Available
Benign vaginal neoplasm16.04.04.001; 21.08.03.002--Not Available
Bladder pain20.02.02.001--Not Available
Blepharitis06.04.04.001; 23.03.04.012--Not Available
Blindness06.02.02.001; 17.17.01.003--Not Available
Blister12.01.06.002; 23.03.01.0010.000278%Not Available
Blood oestrogen decreased13.10.05.0100.001182%Not Available
Blood oestrogen increased13.10.05.0070.000139%Not Available
Blood pressure fluctuation24.06.01.002--Not Available
Blood pressure increased13.14.03.005--Not Available
Blood triglycerides increased13.12.03.001--Not Available
Body temperature increased13.15.01.001--Not Available
Bone disorder15.02.04.004--Not Available
Bone pain15.02.01.0010.000417%
Breast cancer16.10.01.001; 21.05.01.0030.000348%Not Available
Breast discharge21.05.05.0010.000139%Not Available
Breast engorgement18.08.02.001; 21.05.05.002--Not Available
Breast enlargement21.05.04.001--Not Available
Breast malformation03.03.03.002; 21.15.02.004--Not Available
Breast mass21.05.04.0020.000209%Not Available
Breast neoplasm16.10.02.001; 21.05.01.004--Not Available
Breast oedema21.05.05.012--Not Available
Breast pain21.05.05.0030.000626%
Breast swelling21.05.05.0080.000139%Not Available
Breast tenderness21.05.05.0040.001391%Not Available
Bronchitis11.01.09.001; 22.07.01.001--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 17 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene